Stock EXOSENS (FR001400Q9V2)
Sector : Aerospace & Defense – Indices : SBF 120, CAC ALL-TRADABLE
Last update : 24/04/2026 at 17:35:19 – Source: Euronext
Market summary
As of 24/04/2026, stock EXOSENS trades at 63,75 € , with a change of -2,07 % , and a market cap of 3 247 M€. Reference period : 9M 2025.
Price and moving averages
Technical analysis EXOSENS
| 50-day moving average63,59 €0.25 % (above) | Pivot63,93 € |
|---|---|
| Support level57,5 €-9.80 % | Resistance level72,9 €+14.35 % |
| 1-month volatility13,55 % | Annualised volatility46,94 % |
| RSI (14d)49 Neutral | Stochastic signal (14d)Neutre |
| ATR (14d)2,52 High volatility | CMF (21d)0,23 Moderate buying pressure |
| Bollinger bands (20d) Neutral | OBV (21d) Neutral (OBV stable) |
Recent news — EXOSENS
Exosens stock fell by 2.46% this Friday, trading at 63.50 euros compared to 65.10 euros the previous day. This decline occurs in a context of a genera…
Exosens significantly gains ground this Wednesday, driven by an upward revision of the price target by Deutsche Bank published today. The stock moves …
Exosens is trading at 64.20 euros this Tuesday mid-session in Paris, up 2.15% from the previous close. The specialist in optoelectronic components and…
In early afternoon trading on Monday, April 13, Exosens shares were up at €62.00, a 1.81% increase from last Friday's close of €60.90. This positive t…
Exosens drops more than 5% this Friday mid-session, trading at €61.00, while the CAC 40 is up by 0.79% at the same time. This downturn brings the stoc…
Exosens stock significantly declined this Thursday, April 9, dropping 6.63% to 62.65 euros by mid-morning, after closing at 67.10 euros the previous d…
Latest earnings
| Annuels 9M 2025 | |
|---|---|
| Revenue | 327,8m€ |
Guidance
| Revenue outlook | croissance du chiffre d’affaires dans le haut de la fourchette de 15-20% par rapport à 2024 |
|---|---|
| EBITDA outlook | croissance de l’EBITDA ajusté dans le bas de la fourchette de 20-25% par rapport à 2024 |
| Management commentary | Guidance 2025 : croissance du chiffre d’affaires attendue dans le haut de la fourchette de 15-20% et croissance de l’EBITDA ajusté attendue dans le bas de la fourchette de 20-25% par rapport à 2024. TCAM EBITDA ajusté 2024-2026 attendu dans le haut de la fourchette de 15-20%. Cash conversion 2024-2026 attendue entre 70 et 75%. Ratio de levier financier cible d'environ 2x. |
Identified risks and opportunities
Opportunities
- Croissance adressable liée à la vision nocturne et aux applications drones/anti-drones
- Commercialisation des tubes 5G avec commandes significatives (>5 000 tubes)
- Expansion des capacités de production (+40% d’ici 2027) soutenant le développement commercial
- Effets de croissance externe (Noxant, NVLS, Phasics) élargissant le marché adressable
Risks
- Cession de l’activité Amplification par Micro-ondes entraînant une perte comptable sans impact de trésorerie en 2025
- Dépendance aux budgets de Défense et aux évolutions géopolitiques
- Risque d'intégration des acquisitions récentes
- Incertitudes de la demande dans les Sciences de la Vie (marché américain)
Analyses on EXOSENS stock
No analysis has been published on this stock yet.
Frequently asked questions about EXOSENS stock
What does the recent price action of EXOSENS stock show?
EXOSENS stock is currently trading around 63,75 €, down 2,07% and down 0,03% over one week.
Is EXOSENS stock in a support or resistance zone?
Technical levels help place the stock. Support: 57,50 €. Resistance: 72,90 €.
How should the current volatility of EXOSENS stock be interpreted?
Volatility is around 46,94%.
